News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Clinical - Drug Product News (World)
Mylan (MYL) Launches Generic Exforge Tablets 3/31/2015
PHEBURANE Now Available For Distribution In Canada Through Medunik Canada 3/30/2015
Hospira's INFLECTRA (Infliximab) Now Available In Canada 3/30/2015
Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its Novel Stem Cell Drug 'Stempeucel' 3/23/2015
Neovasc Inc. (NVC) Launches Reducer In Select European Countries 3/20/2015
Hatchtech Pty Ltd To Explore Strategic Alternatives For Commercialization Of Xeglyze Lotion In The U.S. 3/18/2015
Actavis (ACT) Receives FDA Approval For VIIBRYD (vilazodone HCl) 20mg Once Daily As A Therapeutic Dose 3/17/2015
Duchesnay inc. Release: Expansion Overseas – Diclectin For Nausea And Vomiting Of Pregnancy (NVP) Now Available In Israel 3/17/2015
Endo Pharmaceuticals (ENDP) Announces The Launch Of NATESTO (Testosterone Nasal Gel), The First And Only Nasal Gel For Testosterone Replacement Therapy 3/16/2015
Yisheng Biopharma Co., Ltd. Release: A New Therapeutic Vaccine Successfully Developed Against Rabies 3/16/2015
Advisory - Jamp Pharma Corp Recalls Jamp-Methotrexate (USP 50mg/2mL) Due To Particulate Matter 3/16/2015
Genovis Is Launching A New Enzyme Product 3/12/2015
Mylan Inc. (MYL) Launches First And Only Available Intermediate Dosage Strengths Of Fentanyl Transdermal System 37.5, 62.5 And 87.5 Mcg/Hr 3/11/2015
Mylan Inc. (MYL) Launches Generic Antabuse Tablets 3/11/2015
Take Charge And Become One Of The Alpha Elite With The Launch Of Hantian Labs' Stimulant Free Testosterone And Performance Booster 3/11/2015
Mylan Inc. (MYL) Launches Generic Subutex Sublingual Tablets 3/11/2015
Vectura Group plc (VEC.L) Release: AirFluSal Forspiro Launched In Portugal And Ireland 3/11/2015
Milan, Italy: BMG Pharma S.r.l Announces The Launch Of Its Proprietary Product Ialuxid Gel In The People's Republic Of China By Luqa Pharmaceuticals 3/10/2015
TWi Pharmaceuticals, Inc. Receives Rare Disease Drug Designation For Its Drug Candidate AC-203 In Taiwan 3/10/2015
Actavis (ACT) Launches Generic Version Of Temovate (Clobetasol Cream 0.05%) 3/9/2015
Ipsen (IPN.PA) Announces Third Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S. In 2015 3/2/2015
Celltrion, Inc. (068270.KQ) Launches World’s First Biosimilar Monoclonal Antibody Remsima In 12 New European Markets 2/25/2015
TWi Pharmaceuticals, Inc. Announces That It Will Sell Its Products In The U.S. Market, Originally Planned To Be Sold By Teva, Through Its Wholly-Owned Subsidiary, TWi Pharmaceuticals USA 2/24/2015
Celgene International Sárl (CELG) Release: ABRAXANE Now Reimbursed In Italy As A First-Line Treatment Of Adult Patients With Metastatic Pancreatic Cancer 2/24/2015
Ferring Pharmaceuticals Announces European Launch Of CORTIMENT MMX (Budesonide) For Ulcerative Colitis, And New Data Re-Confirms Safety And Efficacy 2/20/2015
Aptalis Pharmaceutical Technologies (FRX) Release: Allegra Dry Syrup 5% Launches In Japan 2/20/2015
Teva Pharmaceutical Industries (TEVA) Bolsters Injectable Portfolio With Launch Of Generic Lovenox And Generic Zyvox In The United States 2/17/2015
Hospira Launches First Biosimilar Monoclonal Antibody (mAb) Inflectra (Infliximab) In Major European Markets 2/16/2015
Teijin Limited Release: Small-sized MUCOSOLVAN L Expectorant Tablet 45 Mg Approved In Japan 2/16/2015
Gilead (GILD) Agrees to a Discounted Price of $46,000 for Sovaldi in Europe 2/13/2015
Ex-Smokers Jittery About GlaxoSmithKline (GSK)'s Nicorette Lozenge Shortage 2/11/2015
BMG Pharma S.r.l Obtained A New Indication On Molluscum Contagiosium For CE Marked Proprietary Product Ialuxid Gel 2/9/2015
Daiichi Sankyo (4568.t) Release: SAVAYSA (edoxaban) Now Available In U.S. Pharmacies 2/9/2015
Tianjin Medical University Cancer Hospital Release: Nanocarrier Drugs for Pancreatic Cancer Now Being Produced In China 2/6/2015
Novartis Pharmaceuticals Canada Inc. Release: Now Available In Quebec, Ultibro® Breezhaler®, A Once-Daily Dual Bronchodilator For Chronic Obstructive Pulmonary Disease (COPD) 2/3/2015
Sanofi (SAN.PA) And MannKind Corporation (MNKD) Announce Afrezza®, The Only Inhaled Insulin, Now Available In The U.S. 2/3/2015
Novartis AG (NVS) Sees Price War With Amgen (AMGN), Eli Lilly (LLY) for Blockbuster Psoriasis Market 1/29/2015
Asia's Biggest Vaccine Maker a Huge Threat to Drugmakers Like Merck & Co. (MRK) 1/28/2015
BioSpace (DHX) Poll Finds Whopping 92% of Respondents Believe Discounts Were Offered in Pricing War 1/27/2015
Disneyland Measles Outbreak Casts Shadow on Anti-Vaccination Movement 1/21/2015
International Charity Slams GlaxoSmithKline (GSK), Pfizer (PFE) for High Vaccine Prices 1/20/2015
Eli Lilly (LLY) Claims Innocence as FDA Bans Mystery Cialis-Viagra Concoction Discovered at Plant 1/14/2015
Breaking: J.P. Morgan: Sanofi (SAN.PA) Says Afrezza Will Be Available in 2015, Snubs MannKind Corporation (MNKD) CEO Retirement News 1/13/2015
Hikma Pharmaceuticals (HIK.L) To Launch Colchicine 0.6mg Capsules 1/12/2015
HUYA Bioscience International Announces Regulatory Approval Of Chidamide, The First Selective HDAC Inhibitor In China 1/12/2015
U.K. Cancer Drugs Fund Delists Big Pharmas' Meds; Novartis AG (NVS) Slams Process 1/12/2015
Teva Pharmaceutical Industries Limited (TEVA) Launches Generic Diovan® In The United States 1/7/2015
Novo Nordisk A/S (NVO) Plans to Use 500 Sales Reps to Promote New Obesity Drug 12/30/2014
UK Agency's Rejection of Eli Lilly (LLY), GlaxoSmithKline (GSK), PharmaMar S.A.'s Ovarian Cancer Drugs Stand 12/24/2014
Jazz Pharmaceuticals (JAZZ) Receives FDA Approval For Intravenous Administration Of Erwinaze® (Asparaginase Erwinia Chrysanthemi) 12/22/2014
Actavis (ACT) Ordered To Keep Selling Alzheimer's Pill 12/12/2014
Lupin Ltd. (LUPN.BO) Launches Authorized Genericfor Celebrex Capsules 12/11/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of First Generic Celebrex® Capsules In The United States 12/10/2014
Actavis (ACT) Launches Generic Version Of Celebrex 12/10/2014
Zydus Cadila Launches World's First Biosimilar Of AbbVie (ABBV)'s Humira In India 12/9/2014
Daiichi Sankyo, Inc. (4568.t) Launches New Formulation Of LIXIANA 60 mg Tablets (edoxaban) In Japan 12/8/2014
Otsuka Pharmaceutical Co., Ltd. Release: U.S. FDA Approves The Labeling Update Of Abilify Maintena® (Aripiprazole) For Extended-Release Injectable Suspension To Describe New Clinical Data For The Treatment Of Acutely Relapsed Adults With Schizophrenia 12/8/2014
Basilea Pharmaceutica (BSLN.SW) Announces Launch Of Antibiotic Zevtera(R) (Ceftobiprole Medocaril) In Germany 12/5/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved In Germany 12/4/2014
EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches In India 12/2/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Exforge HCT® Tablets In The United States 12/1/2014
SkyePharma Inc. (SKYE)’s Partner Kyorin Pharmaceutical Co., Ltd. Launches 120-Puff Version Of Flutiform In Japan 12/1/2014
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014
Actavis (ACT) Launches Generic Version Of Intuniv 12/1/2014
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Docetaxel Injection USP 11/24/2014
Perrigo Company (PRGO) Announces The Launch Of A Generic Version Of Astellas' Protopic Ointment 0.1% And 0.03% 11/24/2014
Sanofi (SAN.PA) Aims To Launch 18 New Drugs By 2020 11/21/2014
European Medicines Agency Recommends Availability Of Laboratoire HRA Pharma's Ellaone Emergency Contraceptive Without Prescription 11/21/2014
France Strikes Deal For Gilead Sciences, Inc. (GILD)'s Hep C Drug Sovaldi 11/21/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Over-The-Counter Fexofenadine Hydrochloride 60 Mg And Pseudoephedrine Hydrochloride 120 Mg Extended-Release Tablets 11/20/2014
Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex/ 11/18/2014
AstraZeneca PLC (AZN) Shows Off Strong Drug Pipeline As Pfizer (PFE) Deadline Looms 11/18/2014
Mallinckrodt Pharmaceuticals (MNK) Responds To FDA’s Expected Reclassification Of Methylphenidate ER 11/14/2014
Mallinckrodt Pharmaceuticals (MNK)'s Generic ADHD Drug Does Not Measure Up To Johnson & Johnson (JNJ)'s Concerta: FDA 11/14/2014
Novartis AG (NVS) To Deliver Three Million Malaria Treatments For Kids In Zambia 11/13/2014
Major Medical Centers Ask Congress To Probe Genentech (RHHBY)'s Distribution Changes 11/13/2014
Five Percent Of Medicines In Malaysia Are Counterfeit: Pfizer (PFE) 11/11/2014
Oculus Innovative Sciences, Inc. (OCLS) Commercializes Microcyn®-Based Solution And Hydrogel For Treatment Of Mild-To-Moderate Acne In Europe 11/11/2014
Babies Die While Officials Haggle With Novartis AG (NVS) Over Cost Of Bexsero Vaccine 11/11/2014
When Will Biosimilars Impact The U.S. Market? 10/30/2014
European Medicines Agency Completes Review Of Polymyxin-Based Medicines 10/24/2014
BioSpace’s Favorite FDA Tricks Or Treats 10/24/2014
Takeda Pharmaceuticals And Orexigen Therapeutics, Inc. (OREX) Announce Availability Of CONTRAVE® (naltrexone HCI And bupropion HCI) Extended-Release Tablets For Chronic Weight Management In Obese Adults 10/20/2014
Admedus Cardiocel® To Be Launched In Canada 10/20/2014
Government Of Canada Ships NewLink Genetics' Ebola Vaccine To The WHO 10/20/2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials 10/16/2014
Health Canada Release: Safety Information On The Risk Of Blood Clots With Immunoglobulin Products 10/13/2014
Orexo AB (ORXOF) Submits Application To FDA For Expanded Label Of ZUBSOLV® 10/13/2014
Gilead Sciences, Inc. (GILD)'s Solvadi May Be Barred From UK's Service Plan 10/9/2014
National Institute for Clinical Excellence (NICE) Rejects Another Roche (RHHBY) Leukemia Drug Citing Data Uncertainties 10/6/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To Patients Infected With Ebola Virus 10/6/2014
Janssen-Cilag International NV (JNJ) Release: CHMP Announces Positive Opinion For REZOLSTA™, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat 9/29/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To A French Woman Infected With Ebola Virus 9/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Levalbuterol Inhalation Solution, USP 9/24/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved For The European Union 9/22/2014
Janssen Pharmaceutical Inc. Release: Prezcobix™ Now Available For Canadians Living With HIV 9/17/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
Roche (RHHBY) Battles Counterfeit Rituxin Vials In Germany 9/15/2014
EMD Serono Canada Inc. Announces Launch Of The Eeva® Test In Canada 9/11/2014
Endo International plc (ENDP) Announces Launch Of Authorized Generic Of FORTESTA® Gel 9/8/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Baraclude® Tablets, 0.5mg And 1mg, In The United States 9/4/2014
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden 9/2/2014
BioTie Therapies Corp.: Selincro Enters The Market In Germany 8/29/2014
Fresenius Kabi AG Introduces Acetylcysteine Solution 10% In 4 Ml, 10 Ml And 30 Ml Vials 8/18/2014
Sanofi (France) (SAN.PA), PATH Roll Out First Large-Scale Batches Of Antimalarial Drug 8/12/2014
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche (RHHBY)'s New $152,850 Breast Cancer Drug 8/11/2014
Fresenius Kabi AG Release: Diprivan® (Propofol) Injectable Emulsion, USP Now Available In 10 Ml Vials 8/11/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Launch Of ADASUVE® (Inhalation Powder, loxapine) In Guatemala 8/8/2014
bioCSL Inc. Launches AFLURIA® Shipping Campaign For 2014-2015 Seasonal Influenza 8/5/2014
Troubled GlaxoSmithKline (GSK) Gets A Lift As Express Scripts Inc. Reinstates Lung Drug Advair 8/5/2014
Certara Corporation Launches D360 In Japan To Improve Drug Discovery And Development Productivity 8/4/2014
INNOPHARMA Announces Launch Of Olanzapine For Injection, 10mg/Vial In Canada 7/30/2014
AstraZeneca PLC (AZN) Fights With Pediatrician Group Over Preemie Drug Guidelines 7/29/2014
Perrigo Company (PRGO) Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 7/28/2014
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States 7/24/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
BioTie Therapies Corp.: Selincro Enters The Market In Spain 7/22/2014
Shire Release: Firazyr®: First Subcutaneous Treatment For Acute Attacks Of Rare And Serious Swelling Disorder Now Available In Canada 7/21/2014
BioAlliance Pharma Announces The Launch Of Sitavig® In The United States By Its Partner Innocutis 7/21/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
Bial And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014
The International Myeloma Foundation Says IMNOVID® (Pomalidomide), The Newest Medication For Advanced Cases Of Multiple Myeloma, Is Approved For Reimbursement In Sweden, Spain, And Switzerland 7/10/2014
Tianyin Pharmaceutical Co, Inc. Receives GMP For Tablets Formulation In Early July 7/7/2014
Novartis AG (NVS) Unveils Stronger Drug In Bid To Boost Malaria Treatment 7/7/2014
Novartis AG (NVS) Begins Shipment Of Seasonal Influenza Vaccines To US Market For The 2014-2015 Season 7/3/2014
Biogen Idec Canada Release: British Columbia To Reimburse TECFIDERA™, A First-Line Oral Treatment For Multiple Sclerosis 6/25/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Paricalcitol Capsules 6/25/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: AMITIZA® (Lubiprostone) Receives National Institute for Clinical Excellence (NICE) Recommendation 6/18/2014
UK's Cost Agency Not Ready To Back Gilead Sciences, Inc. (GILD)'s Controversial Hepatitis C Drug 6/17/2014
Cepheid (CPHD) Announces European Release Of Xpert Carba-R, A Molecular Test For Rapid And Accurate Detection Of Carbapenemase-Producing Gram-Negative Bacteria 6/16/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: ENTYVIO™ (vedolizumab) Now Available In The United States For The Treatment Of Adults With Moderately To Severely Active Ulcerative Colitis And Crohn's Disease 6/16/2014
Italy To Fund Unapproved Use Of Roche (RHHBY) Drug To Cut Costs; Move Startles The Industry 6/13/2014
Medivir AB (MVRBF) Release: OLYSIO™ Available Soon In All Nordic Countries For The Treatment Of Adults With Hepatitis C Genotype 1 And 4 Infection 6/10/2014
Both Are Roche (RHHBY)'s Drugs, But Which One Could Save The U.S. $3 Billion? 6/5/2014
Genzyme Corporation (GENZ)'s Lemtrada Recommended For Reimbursement On NHS By The National Institute for Clinical Excellence (NICE) 5/28/2014
Polyplus Transfection Launches A New Transfection Reagent For Bioproduction 5/28/2014
ULURU Inc. Announces Shipments Of Altrazeal® To Italy, Spain And Portugal 5/27/2014
TOLMAR Pharmaceuticals Established To Market ELIGARD For Advanced Prostate Cancer In The U.S. And Puerto Rico 5/16/2014
Actavis (ACT) Launches Generic Version Of Catapres-TTS® 5/8/2014
Otsuka Pharmaceutical Co., Ltd. Release: New Once-Monthly Treatment For Schizophrenia, ABILIFY MAINTENA™ (Aripiprazole For Prolonged Release Injectable Suspension), Now Available In Canada 5/5/2014
Medivir AB (MVRBF) Release: Adasuve Will Now Be Launched In Sweden, Norway, Finland, And Denmark 4/30/2014
Heat On Roche (RHHBY) To Cut Kadcyla Price After National Institute for Clinical Excellence (NICE) Says "No" 4/23/2014
Stolen Roche (RHHBY) Cancer Drug Found On Market 4/18/2014
Ferring Pharmaceuticals Release: UK National Institute for Clinical Excellence (NICE) Guidance Recommends FIRMAGON® (Degarelix) For The Treatment Of Advanced Hormone-Dependent Prostate Cancer Only In People With Spinal Metastases Who Present With Signs Or Symptoms Of Impending Spinal Cord Compression (ISCC) 4/15/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Lunesta® Tablets In The United States 4/15/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Plans To Gradually Phase-Out Of Ranbaxy Laboratories (RANBAXY.BO)-Branded Drugs In U.S. 4/9/2014
Swedish Orphan Biovitrum Becomes Market Authorisation Holder For Xiapex In Europe 4/7/2014
Aerocrine Release: National Institute for Clinical Excellence (NICE) Recommends The Use Of Exhaled Nitric Oxide (Feno) Testing To Help Diagnose And Manage Asthma 4/2/2014
Swedish Orphan Biovitrum Assumes Direct Responsibility For Orfadin® (Nitisinone) In U.S. And Canada And Introduces Orfadin4U™ 4/1/2014
Sanofi (France) (SAN.PA) Release: National Institute for Clinical Excellence (NICE) Rejects Life-Extending Bowel Cancer Drug Two Weeks After Scottish Approval 3/25/2014
UK Cancer Drugs Fund Adds Roche (RHHBY), Celgene Corporation (CELG) And Exelixis, Inc. (EXEL) Drugs 3/24/2014
UK Cost Agency Says "No" To Bayer AG (BAYN.DE) Prostate Cancer Drug Xofigo 3/24/2014
Toyama Chemical NDA Approval Of “AVIGAN Tablet 200mg” In Japan For The Anti-influenza Virus Drug 3/24/2014
H. Lundbeck A/S (LUN.CO) And Otsuka Pharmaceutical Co., Ltd. Initiate European Launch Of Abilify Maintena® (Aripiprazole), A Once-Monthly Formulation For The Treatment Of Schizophrenia 3/17/2014
NicOx SA (COX.PA) Launches Adenoplus® And Xailin™ Dry Eye Product Range In Europe 3/17/2014
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Announce The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In Romania 3/14/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Receives Notice That Second Indication For AMITIZA For Opioid-Induced Constipation Is Not Approved By Medicines And Healthcare Products Regulatory Agency In U.K. 3/13/2014
Roche (RHHBY) And Jiangsu Province Bring Down High Cost Of Breast Cancer Drug 3/13/2014
French Competition Regulator Probes Roche (RHHBY), Novartis AG (NVS) 3/12/2014
Novartis AG (NVS) Muscle Drug Sales May Reach $4 Billion, According To MorphoSys AG 3/7/2014
British Watchdog Wants U.S. Biotech Alexion Pharmaceuticals Inc. (ALXN) To Justify Cost Of Drug 3/5/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches ADASUVE® In U.S. 3/3/2014
Bayer AG (BAYN.DE) Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs 2/28/2014
Essex Medipharma To Distribute Pfizer Inc. (PFE) Glaucoma Eye Drops In China 2/25/2014
Double-Crane Pharmaceutical Co., Ltd. To Distribute Sagent Pharmaceuticals, Inc. Pediatric Drug In China 2/14/2014
Jazz Pharmaceuticals plc (JAZZ) Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension 2/12/2014
Mylan Inc. (MYL) Launches First Trastuzumab Biosimilar, Hertraz™, In India 2/3/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces Grupo Ferrer Internacional S.A.'s Launch Of ADASUVE® (Staccato® Loxapine) In Spain Triggering A $1 Million Milestone Payment 1/23/2014
Eisai Company, Ltd. (ESALY.PK) Announces Launch Of New "Crystal Veil Mask Bokin 24 Mint" Face Mask Spray Containing Long-Acting Antimicrobial Agent Etak 1/22/2014
H. Lundbeck A/S (LUN.CO)'s Brintellix® (Vortioxetine) For The Treatment Of Major Depressive Disorder In Adults Is Now Available In U.S. Pharmacies 1/21/2014
BioCon Limited (BIOCON.NS) Hits Roche (RHHBY) First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin 1/21/2014
Vectura Group plc (VEC.L)'s AirFluSal® Forspiro® Launched In Denmark 1/20/2014
Roche (RHHBY) Resolves U.S. Shortage Of Tamiflu For Children 1/17/2014
Seattle Genetics, Inc. (SGEN) Announces ADCETRIS® (Brentuximab Vedotin) Approval In Japan For The Treatment Of Relapsed Or Refractory Hodgkin Lymphoma And Anaplastic Large Cell Lymphoma 1/17/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Announces Availability Of FAMPYRA® In Ireland To Treat Walking Impairment In Adults With Multiple Sclerosis 1/15/2014
pSivida Corp (PSDV) Reports First Orders For ILUVIEN® Shipped For U.K. National Health Service Hospitals Less Than Seven Weeks After Final National Institute for Clinical Excellence (NICE) Guidance 1/13/2014
UK Lawmakers Criticizes The Government For Spending $702 Million On Roche (RHHBY)'s Tamiflu When Some Researchers Doubt The Medicine's True Efficacy 1/6/2014
Eisai Company, Ltd. (ESALY.PK) Announces Launch of Antiepileptic Drug Fycompa In U.S. 1/6/2014
China Halts Imports Of Pfizer Inc. (PFE)'s Diflucan On Paperwork Glitch 12/31/2013
PhotoCure Release: Regulatory Update On Cevira 12/27/2013
Ipsen (IPN.PA) Prepares For The Resupply Of Increlex® In Europe 12/18/2013
MediGene AG (MDGEF.PK)'s Drug Veregen® Launched In Norway And Sweden 12/18/2013
Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc. (GILD)'s Sovaldi™ (Sofosbuvir) For The Treatment Of Chronic Hepatitis C 12/16/2013
AstraZeneca PLC (AZN) And Bristol-Myers Squibb Company (BMY) Pull Diabetes Drug From Germany 12/16/2013
Notices Sent To Ranbaxy Laboratories (RANBAXY.BO), Cipla Ltd. For Overcharging 12/10/2013
Medivir AB (MVRBF)'s Simeprevir Is Now Available For Hepatitis C Patients In Japan, USA And Canada 12/10/2013
EU Agency Starts In-Depth Review Of Ariad Pharmaceuticals, Inc. (ARIA) Leukemia Drug 12/6/2013
Pfizer Inc. (PFE), Hanmi Pharmaceutical, Co., Ltd Brawl Over Design Of Viagra Pill 12/5/2013
Teva Pharmaceutical Industries Limited (TEVA) Announces Additional Regulatory Exclusivity For TREANDA® (Bendamustine HCI) For Injection 11/27/2013
FDA Lifts Constraints On GlaxoSmithKline (GSK) Diabetes Drug Avandia 11/26/2013
Sosei Group Corporation: Once-Daily Ultibro® Inhalation Capsules (QVA149) For COPD Launched In Japan 11/20/2013
Skyepharma PLC (SKYEF)'s Partner Kyorin Launches Flutiform® In Japan 11/19/2013
WuXi PharmaTech Co., Ltd. To Produce New Cancer Drug For Pharmacyclics, Inc. (PCYC) 11/15/2013
NicOx SA (COX.PA) Launches Sjö™ In The U.S. And Partners With The Sjogren's Syndrome Foundation 11/12/2013
Allied Healthcare Group (AHZ:AU) Makes First Sale of Cardiocel ® Into Europe 11/8/2013
National Institute for Clinical Excellence (NICE): Final Draft OK for Lucentis in Rare Eye Condition 10/25/2013
ADImmune Corporation of Taiwan Readies Flu Vaccine for China 10/25/2013



//-->